TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
129.71
-2.74 (-2.07%)
Oct 28, 2025, 4:00 PM EDT - Market closed
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $4.42 billion as of October 29, 2025. Its market cap has decreased by -2.46% in one year.
Market Cap
4.42B
Enterprise Value
4.54B
1-Year Change
-2.46%
Ranking
Category
Stock Price
$129.71
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $4.42B, an increase of 877.25%. That is a compound annual growth rate of 42.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 4.52B | 115.78% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | 540.50M | 34.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |